Smith & Nephew Receives FDA Clearance for ACTICOAT Moisture Control
NEW YORK -- Smith & Nephew's U.S. Advanced Wound Management division today announced that the Food and Drug Administration (FDA) has given clearance of its newest absorbent antimicrobial barrier dressing, ACTICOAT Moisture Control.
The clearance and introduction of ACTICOAT Moisture Control complements the company's existing ACTICOAT range. These wound-care products to feature the patented Silcryst nanocrystalline silver technology that provides antimicrobial barrier protection.
ACTICOAT Moisture Control was developed over the last two years, through collaboration between Smith & Nephew and NUCRYST Pharmaceuticals. Smith & Nephew launched the product at the SAWC Convention on April 22 in San Diego, as an extension to the existing ACTICOAT family.
The current ACTICOAT range, which encompass a three-day, seven-day and absorbent product have been shown to be bactericidal against a broad range of pathogens, including MRSA and VRE, and have led the way in both burn and chronic wound care. ACTICOAT Moisture Control, with an extended wear time up to seven days, reduces the number of dressing changes and the resources needed to change multiple dressings, adding to the comfort and quality of life of the patient.
Antimicrobial barrier dressings are increasingly used in the advanced wound care market as a barrier to bacterial penetration, a major cause of delays and complications to wound healing. As an effective barrier to pathogenic bacteria, ACTICOAT Moisture Control may help avoid serious complications associated with nosocomial outbreaks, wound infection may be avoided and duration of hospitalization and healthcare related costs reduced proportionately.
The introduction of ACTICOAT Moisture Control now offers the bactericidal protection synonymous with the ACTICOAT range in a highly absorbent, easy-to-use format. New ACTICOAT Moisture Control eliminates the threats to healing and provides powerful antimicrobial barrier protection to chronic and acute wounds.
"We are very excited to announce that we have added ACTICOAT Moisture Control to the Smith & Nephew portfolio. This new product allows us to provide even more options for our valued customers as they treat wounds that affect their patients. We strive to help people regain their lives and the addition of ACTICOAT Moisture Control will help us do just that," says Jim Lodigiani, U.S. wound management president.
Source: Smith & Nephew, Inc.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Why Clinical Expertise Is the Cornerstone to Your Most Profitable Business Line
November 14th 2024Perioperative nurses bring vital skills in patient safety, infection control, and quality improvement. They enhance surgical outcomes and support health care systems during complex, high-risk procedures.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
Blood Product Overtransfusion Is a Global Issue: Here Are 5 Reasons the Practice Must Change
October 9th 2024If a patient receives treatment or therapy that they do not need, it can cause unnecessary harm. This is true for medications, surgeries, and medical procedures, especially blood transfusions.
